Biotechnology & Life Sciences

The faultline

Whether claimed biological effects, measurements, and interventions remain reliable when tested in living systems and clinically meaningful settings.

Recent Activity

2026-08-29FR-BT-0002First participant dosed in ER-100 Phase 1 trial admitted with structured provenance at admission under PA-006.Escalating

2026-08-21FR-BT-0005IN-001 through IN-007 admitted as the initial two-sided evidence set.Escalating

2026-08-21FR-BT-0005FR-BT-0005 admitted following bounded PROG-BT coverage review and formal material-commitment reconstruction.Escalating

Evidence Trajectories - PROG-BT

View Biotechnology & Life Sciences trajectoriesBT records are brought forward within the full archive.

Frontier Records — PROG-BT

FR-BT-0001Senolytic Therapies — Meaningful Human Healthspan ExtensionEscalating1 assessment2024-01-15 FR-BT-0002Epigenetic Reprogramming — Biological Age Reversal Without Identity LossEscalating3 assessments2024-01-15 FR-BT-0003Biological Age Biomarker Panels — Predictive Validity for Age-Related DeclineFragmenting1 assessment2024-01-15 FR-BT-0004Liquid Biopsy — Early Cancer Detection Before Conventional DiagnosisFragmenting2 assessments2024-01-15 FR-BT-0005Gene-Edited Porcine Kidneys — Durable Human Renal ReplacementEscalating1 assessment2026-08-21

No current programme-level diagnosis.